Human Complement Receptor 1 Polymorphisms
Publisher
Springer Singapore
Reference24 articles.
1. Bellamy, R., Kwiatkowski, D. and Hill, A.V.S. (1998) Absence of an association between intercellular adhesion molecule-1, complement receptor-1 and interleukin-1 receptor antagonist gene polymorphisms and severe malaria in a West African population. Trans. R. Soc. Trop. Med. Hyg. 92:312-316. 2. Birmingham, D.J., Chen, W., Liang, G., Schmitt, H.C., Gavit, K., and Nagaraja, H.N. (2003) A CR1 polymorphism associated with constitutive erythrocyte CR1 levels affects binding to C4b but not C3b. Immunology 108: 531–538. 3. Birmingham, D.J., Irshaid, F., Gavit, K.F., Nagaraja, H.N., Yu, C.Y., Rovin, B.H., and Hebert, L.A. (2007) A polymorphism in the type one complement receptor (CR1) involves an additional cysteine within the C3b/C4b binding domain that inhibits ligand binding. Mol Immunol 44: 3510–3516. 4. Cockburn, I.A., Mackinnon, M.J., O’Donnell, A., Allen, S.J., Moulds, J.M., Baisor, M. et al. (2004) A human complement receptor 1 polymorphism that reduces Plasmodium falciparum rosetting confers protection against severe malaria. Proc. Natl. Acad. Sci. USA 101:272-277. 5. Daniels G, Flegel WA, Fletcher A, Garratty G, Levene C, Lomas-Francis C, Moulds JM, Moulds JJ, Olsson ML, Overbeeke MA, Poole J, Reid ME, Rouger P, van der Schoot CE, Scott M, Sistonen P, Smart E, Storry JR, Tani Y, Yu LC, Wendel S, Westhoff CM, Zelinski T (2007). International Society of Blood Transfusion Committee on Terminology for Red Cell Surface Antigens: Cape Town report. Vox Sang, 92(3):250-3.
|
|